The primary objective of this trial is to demonstrate that the fixed-dose combination of
T80/HCTZ25 is superior as first line therapy in reducing seated trough cuff Systolic Blood
Pressure(SBP) compared to the monotherapy of T80 in patients with grade 2 or grade 3
hypertension (SBP>=160 mmHg and Diastolic Blood Pressure(DBP)>=100 mmHg).
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
502.550.35901 Boehringer Ingelheim Investigational Site, Sofia, Bulgaria
502.550.35902 Boehringer Ingelheim Investigational Site, Sofia, Bulgaria
502.550.35903 Boehringer Ingelheim Investigational Site, Sofia, Bulgaria
502.550.35904 Boehringer Ingelheim Investigational Site, Sofia, Bulgaria
502.550.35905 Boehringer Ingelheim Investigational Site, Sofia, Bulgaria
502.550.35908 Boehringer Ingelheim Investigational Site, Sofia, Bulgaria
502.550.35909 Boehringer Ingelheim Investigational Site, Sofia, Bulgaria
502.550.35910 Boehringer Ingelheim Investigational Site, Sofia, Bulgaria
502.550.35911 Boehringer Ingelheim Investigational Site, Sofia, Bulgaria
502.550.35906 Boehringer Ingelheim Investigational Site, Stara Zagora, Bulgaria
502.550.86004 Boehringer Ingelheim Investigational Site, Changsha, China
502.550.86003 Boehringer Ingelheim Investigational Site, Guangzhou, Guangdong Province, China
502.550.86008 Boehringer Ingelheim Investigational Site, QingDao, China
502.550.86001 Boehringer Ingelheim Investigational Site, Shanghai, China
502.550.86002 Boehringer Ingelheim Investigational Site, Shanghai, China
502.550.86009 Boehringer Ingelheim Investigational Site, Shenyang, China
502.550.86007 Boehringer Ingelheim Investigational Site, Tianjin, China
502.550.86010 Boehringer Ingelheim Investigational Site, Zhengzhou, China
502.550.3302D Boehringer Ingelheim Investigational Site, Aigrefeuille S/Maine, France
502.550.3305I Boehringer Ingelheim Investigational Site, Aix-en-Provence, France
502.550.3305G Boehringer Ingelheim Investigational Site, Aubagne, France
502.550.3301H Boehringer Ingelheim Investigational Site, Briollay, France
502.550.3301K Boehringer Ingelheim Investigational Site, Cholet, France
502.550.3302I Boehringer Ingelheim Investigational Site, Corsept, France
502.550.3302C Boehringer Ingelheim Investigational Site, Donges, France
502.550.3302B Boehringer Ingelheim Investigational Site, La Montagne, France
502.550.3306A Boehringer Ingelheim Investigational Site, Louvigné de Bais, France
502.550.3303A Boehringer Ingelheim Investigational Site, Marseille, France
502.550.3303D Boehringer Ingelheim Investigational Site, Marseille, France
502.550.3303F Boehringer Ingelheim Investigational Site, Marseille, France
502.550.3304A Boehringer Ingelheim Investigational Site, Marseille, France
502.550.3304D Boehringer Ingelheim Investigational Site, Marseille, France
502.550.3304F Boehringer Ingelheim Investigational Site, Marseille, France
502.550.3304J Boehringer Ingelheim Investigational Site, Marseille, France
502.550.3305A Boehringer Ingelheim Investigational Site, Marseille, France
502.550.3301A Boehringer Ingelheim Investigational Site, Murs Erigne, France
502.550.3301I Boehringer Ingelheim Investigational Site, Murs-Erigne, France
502.550.3302A Boehringer Ingelheim Investigational Site, Nantes, France
502.550.3302E Boehringer Ingelheim Investigational Site, Nantes, France
502.550.3301E Boehringer Ingelheim Investigational Site, Parcay-les-Pins, France
502.550.3303C Boehringer Ingelheim Investigational Site, Roquevaire, France
502.550.3301F Boehringer Ingelheim Investigational Site, Segre, France
502.550.3302G Boehringer Ingelheim Investigational Site, St Aubin les Châteaux, France
502.550.3306F Boehringer Ingelheim Investigational Site, St Jouan des Guerets, France
502.550.3307A Boehringer Ingelheim Investigational Site, Thouars, France
502.550.3301J Boehringer Ingelheim Investigational Site, Vihiers, France
502.550.99501 Boehringer Ingelheim Investigational Site, Tbilisi, Georgia
502.550.99502 Boehringer Ingelheim Investigational Site, Tbilisi, Georgia
502.550.99503 Boehringer Ingelheim Investigational Site, Tbilisi, Georgia
502.550.99504 Boehringer Ingelheim Investigational Site, Tbilisi, Georgia
502.550.99505 Boehringer Ingelheim Investigational Site, Tbilisi, Georgia
502.550.99506 Boehringer Ingelheim Investigational Site, Tbilisi, Georgia
502.550.99507 Boehringer Ingelheim Investigational Site, Tbilisi, Georgia
502.550.99508 Boehringer Ingelheim Investigational Site, Tbilisi, Georgia
502.550.82008 Boehringer Ingelheim Investigational Site, Cheonan, Korea, Republic of
502.550.82009 Boehringer Ingelheim Investigational Site, Daegu, Korea, Republic of
502.550.82001 Boehringer Ingelheim Investigational Site, Goyang, Korea, Republic of
502.550.82003 Boehringer Ingelheim Investigational Site, Gwangju, Korea, Republic of
502.550.82002 Boehringer Ingelheim Investigational Site, Seoul, Korea, Republic of
502.550.82005 Boehringer Ingelheim Investigational Site, Seoul, Korea, Republic of
502.550.82006 Boehringer Ingelheim Investigational Site, Seoul, Korea, Republic of
502.550.82007 Boehringer Ingelheim Investigational Site, Seoul, Korea, Republic of
502.550.82011 Boehringer Ingelheim Investigational Site, Seoul, Korea, Republic of
502.550.82012 Boehringer Ingelheim Investigational Site, Seoul, Korea, Republic of
502.550.82013 Boehringer Ingelheim Investigational Site, Seoul, Korea, Republic of
502.550.82004 Boehringer Ingelheim Investigational Site, Suwon, Korea, Republic of
502.550.82010 Boehringer Ingelheim Investigational Site, Wonju, Korea, Republic of
502.550.40002 Boehringer Ingelheim Investigational Site, Baia Mare Maramures, Romania
502.550.40003 Boehringer Ingelheim Investigational Site, Braila, Romania
502.550.40001 Boehringer Ingelheim Investigational Site, Bucharest, Romania
502.550.40010 Boehringer Ingelheim Investigational Site, Bucharest, Romania
502.550.40012 Boehringer Ingelheim Investigational Site, Bucharest, Romania
502.550.40009 Boehringer Ingelheim Investigational Site, Cluj Napoca, Romania
502.550.40011 Boehringer Ingelheim Investigational Site, Cluj Napoca, Romania
502.550.40006 Boehringer Ingelheim Investigational Site, Iasi, Romania
502.550.40004 Boehringer Ingelheim Investigational Site, Oradea, Romania
502.550.40005 Boehringer Ingelheim Investigational Site, Sibiu, Romania
502.550.40008 Boehringer Ingelheim Investigational Site, Tg. Mures, Romania
502.550.07001 Boehringer Ingelheim Investigational Site, Moscow, Russian Federation
502.550.07002 Boehringer Ingelheim Investigational Site, Moscow, Russian Federation
502.550.07003 Boehringer Ingelheim Investigational Site, Moscow, Russian Federation
502.550.07004 Boehringer Ingelheim Investigational Site, Moscow, Russian Federation
502.550.07005 Boehringer Ingelheim Investigational Site, Moscow, Russian Federation
502.550.07006 Boehringer Ingelheim Investigational Site, Moscow, Russian Federation
502.550.07007 Boehringer Ingelheim Investigational Site, St. Petersburg, Russian Federation
502.550.07008 Boehringer Ingelheim Investigational Site, St. Petersburg, Russian Federation
502.550.07009 Boehringer Ingelheim Investigational Site, St. Petersburg, Russian Federation
502.550.07010 Boehringer Ingelheim Investigational Site, St.Petersburg, Russian Federation
502.550.01008 Boehringer Ingelheim Investigational Site, Athens, Alabama, United States
502.550.01019 Boehringer Ingelheim Investigational Site, Mobile, Alabama, United States
502.550.01015 Boehringer Ingelheim Investigational Site, Lomita, California, United States
502.550.01003 Boehringer Ingelheim Investigational Site, Colorado Springs, Colorado, United States
502.550.01014 Boehringer Ingelheim Investigational Site, Fort Lauderdale, Florida, United States
502.550.01002 Boehringer Ingelheim Investigational Site, Louisville, Kentucky, United States
502.550.01011 Boehringer Ingelheim Investigational Site, New Iberia, Louisiana, United States
502.550.01009 Boehringer Ingelheim Investigational Site, New Orleans, Louisiana, United States
502.550.01018 Boehringer Ingelheim Investigational Site, Olive Branch, Mississippi, United States
502.550.01006 Boehringer Ingelheim Investigational Site, St. Louis, Missouri, United States
502.550.01016 Boehringer Ingelheim Investigational Site, Charlotte, North Carolina, United States
502.550.01007 Boehringer Ingelheim Investigational Site, Greensboro, North Carolina, United States
502.550.01005 Boehringer Ingelheim Investigational Site, Cincinnati, Ohio, United States
502.550.01001 Boehringer Ingelheim Investigational Site, Cleveland, Ohio, United States
502.550.01017 Boehringer Ingelheim Investigational Site, Houston, Texas, United States
502.550.01020 Boehringer Ingelheim Investigational Site, Houston, Texas, United States
502.550.01012 Boehringer Ingelheim Investigational Site, San Antonio, Texas, United States
502.550.01004 Boehringer Ingelheim Investigational Site, Arlington, Virginia, United States